Marktgröße und -anteil für Perfusionsradiologie nach Anwendung (Gehirnbildgebung, Beatmungsbildgebung, Herz-Kreislauf-Bildgebung); Endverbraucher – Globale Angebots- und Nachfrageanalyse, Wachstumsprognosen, Statistikbericht 2025–2037

Marktanalyse Nordamerika

By 2037, North America perfusion radiology market is likely to capture over 36.2% share due to its developed and adaptive healthcare industry. The general availability of advanced medical facilities and diagnosing services across the region is the pivotal driving factor of this sector. Changing lifestyles in developed countries such as the U.S. and Canada have increased the prevalence of cardiac fatalities, making them the major investors in this field. According to an article released by the NLM, in December 2023, the CVD mortality rate in North America ranged between 99.4 and 191.6 per 10,000 in 2o22. The top contributors of CVD-caused age-standardized DALYs were ischemic heart disease, all stroke subtypes, and hypertensive heart disease.

The U.S. is among those high-income countries that significantly contribute to the growth of the regional perfusion radiology market. In addition, the availability of extensive insurance coverage is among the key influencers, encouraging both patients and service providers to engage their capital in this field. Domestic tech firms are now showing interest in developing advanced management solutions to automate the processing of complex analytical imaging data. For instance, in November 2022, Viz.ai partnered with Cercare Medical to integrate fully automated, simple-to-use, patient-specific perfusion software in its platform, broadening the company’s imaging portfolio.

Canada is accumulating financial and promotional forces to invest heavily in the perfusion radiology market to revamp the gap between survival rates and radiology resources. The country is now focusing on utilizing advanced technology as a financial cushion for its declining healthcare share in GDP. The governing authorities are now being pushed to draft roadmaps to multiply and leverage their medical imaging facilities for reduced wait times and improved patient outcomes. According to a plan, published by the Canadian Association of Radiologists, in August 2023, 9 out of 10 citizens of the country recommended the Federal Government to invest in healthcare imaging. It further outlined a USD 2 billion funding for radiology equipment.

APAC Market Statistics

Asia Pacific is one of the fastest-growing regions in the perfusion radiology market and is estimated to generate notable revenue by the end of 2037. The region is highly focused on upgrading its medical accommodations by investing in infrastructure and research. In addition, dedicated and collaborative R&D projects empower radiology with digitalization to deliver more accurate and effective results. For instance, in November 2022, a team of researchers at Kyushu University developed a revolutionary technology to visualize pulmonary hemodynamics by using Dynamic Digital Radiography (DDR) from Konica Minolta. The newly introduced pulmonary perfusion imaging technique can diagnose chronic thromboembolic pulmonary hypertension without the need for contrast media.

India is estimated to gain traction in the perfusion radiology market due to the notable expansion of the medical device industry in this country. With the government-released initiatives and subsidiary policies around the Made in India campaign, it is cultivating domestic resources to empower its manufacturing capacity of radiology devices. According to the IBEF data, published in August 2024, the government of India launched a new scheme for domestic medical imaging device component manufacturers to eliminate their reliance on imports. It confirmed a 20% capital subsidy on marginal investments for companies associated with manufacturing essential parts for digital X-ray, CT scan, and MRI machines.

China, with a strong emphasis on the manufacturing and assembling industry, is fostering opportunities for the perfusion radiology market. Besides supplying its own patient population and healthcare institutes, the country is also proactively associated with the international trading of medical equipment. According to 2022 OEC data, China ranked among the top 5 largest exporters of medical devices in the world with an export value of USD 12 billion. The country also secured an import value of USD 10.1 billion for this industry in the same year. This is an indication of a healthy marketplace for medical device businesses including perfusion imaging systems, inspiring domestic companies to upscale production.